BRAF Mutant Gastrointestinal Stromal Tumor: First report of...

Oncotarget 2013 / 02 Vol. 4; Iss. 2

BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

Falchook, Gerald S., Trent, Jonathan C., Heinrich, Michael C., Beadling, Carol, Patterson, Janice, Bastida, Christel C., Blackman, Samuel C., Kurzrock, Razelle
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Journal:
Oncotarget
DOI:
10.18632/oncotarget.864
Date:
February, 2013
File:
PDF, 2.01 MB
2013
Conversion to is in progress
Conversion to is failed